
iXO Private Equity backs CBM
iXO Private Equity has provided French medical diagnostics laboratory CBM with growth capital funding of an undisclosed amount.
The venture firm's investment strategy would however value the contribution in the €0.5-10m range. The fresh funds will enable the firm to expand the number of laboratories it operates from three to around ten within two years.
CBM also aims to double its turnover within this time frame - with a €20m target - and increase its number of staff from 100 to 160.
Founded in 1999, CBM is a medical analysis laboratory based in Toulouse. With a broad range of diagnostics on offer - including bacteriology, immunology and biochemistry - CBM targets both individuals and institutions such as private clinics and retirement homes.
The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.
If you have any information regarding this transaction, please contact Grégoire Gille on +44 20 7484 9824 or gregoire.gille@incisivemedia.com
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater